BackReviva Pharmaceuticals Holdings - Warrants (25/12/2025) Overview

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) Net Tangible Assets

Track Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s net tangible assets ($13T) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$13079.36B
↑ 287475126.58% YoYΔ $13079.36B vs prior year quarter

Peer trimmed avg / median

Loading

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) Net Tangible Assets History

Loading

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) vs. peers: Net Tangible Assets Comparison

Loading

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) (RVPHW) FAQ

As of the most recent data (September 2026), RVPHW shows a net tangible assets of $13T. That compares with $4.5M in the prior-year period — up 287475126.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RVPHW's net tangible assets is now $13T (was $4.5M) — a 287475126.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) is outperforming or lagging.

Tracking RVPHW's net tangible assets over time shows whether Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $13T That compares with $4.5M in the prior-year period — up 287475126.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $13T) with ownership activity and broader fundamentals.

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s net tangible assets is $13T; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.